Literature DB >> 24294391

Soft tissue perineurioma and other unusual tumors in a patient with neurofibromatosis type 1.

Inga-Marie Schaefer1, Philipp Ströbel, Aung Thiha, Jan Martin Sohns, Christian Mühlfeld, Stefan Küffer, Gunther Felmerer, Adam Stepniewski, Silke Pauli, Abbas Agaimy.   

Abstract

Perineurioma is a rare benign peripheral nerve sheath tumor featuring perineurial differentiation. Perineurioma occurs sporadically with only one reported case in the setting of neurofibromatosis type 1 (NF-1). We present a 6.7-cm soft tissue perineurioma of the lower leg in a 51-year-old man with proven NF-1. The tumor displayed whorled and fascicular pattern with infiltrative margins and expressed EMA, GLUT-1, claudin-1, and CD34. Electron microscopy confirmed diagnosis. Furthermore, lipomatosis, cutaneous angiomatous nodules, vasculopathy, and iliac spine lesion consistent with non-ossifying fibroma were observed. Tumor DNA revealed no NF2 mutations or chromosomal aberrations but a germline NF1-deletion (c.449_502delTGTT) was detected in his blood sample. His brother displayed neurofibromas, duodenal ganglioneuroma and colonic juvenile polyp, and his mother a neurofibroma, cutaneous squamous cell carcinoma, and jejunal gastrointestinal stromal tumor (GIST); both were affected by NF-1. In conclusion, perineurioma may rarely be NF-1 related and should be included in the spectrum of neoplasms occurring in this disorder.

Entities:  

Keywords:  NF1; Perineurioma; neurofibromatosis; soft tissue; vasculopathy

Mesh:

Substances:

Year:  2013        PMID: 24294391      PMCID: PMC3843285     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  14 in total

Review 1.  Soft-tissue perineurioma. Evidence for an abnormality of chromosome 22, criteria for diagnosis, and review of the literature.

Authors:  C Giannini; B W Scheithauer; R B Jenkins; R A Erlandson; A Perry; T J Borell; R S Hoda; J M Woodruff
Journal:  Am J Surg Pathol       Date:  1997-02       Impact factor: 6.394

2.  Neurofibromatosis associated with malignant neurofibromas.

Authors:  W A Knight; W K Murphy; J A Gottlieb
Journal:  Arch Dermatol       Date:  1973-05

Review 3.  Soft tissue perineurioma: clinicopathologic analysis of 81 cases including those with atypical histologic features.

Authors:  Jason L Hornick; Christopher D M Fletcher
Journal:  Am J Surg Pathol       Date:  2005-07       Impact factor: 6.394

4.  The neurofibromatosis type 2 gene is mutated in perineurial cell tumors: a molecular genetic study of eight cases.

Authors:  J Lasota; J F Fetsch; A Wozniak; B Wasag; R Sciot; M Miettinen
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

5.  Hybrid peripheral nerve sheath tumors, including a malignant variant in type 1 neurofibromatosis.

Authors:  Denisa Kacerovska; Michal Michal; Naoto Kuroda; Azusa Tanaka; Radek Sima; Natalja Denisjuk; Boris Kreuzberg; Renata Ricarova; Dmitry V Kazakov
Journal:  Am J Dermatopathol       Date:  2013-08       Impact factor: 1.533

6.  Ultrastructural identification of a benign perineurial cell tumor.

Authors:  S S Lazarus; L D Trombetta
Journal:  Cancer       Date:  1978-05       Impact factor: 6.860

7.  Site-independent prognostic value of chromosome 9q loss in primary gastrointestinal stromal tumours.

Authors:  Bastian Gunawan; Hans-Jürgen Schulten; Anja von Heydebreck; Bettina Schmidt; Christina Enders; Jörg Höer; Claus Langer; Phillip Schüler; Christian G Schindler; Jens Kuhlgatz; László Füzesi
Journal:  J Pathol       Date:  2004-04       Impact factor: 7.996

8.  Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain.

Authors:  R Fahsold; S Hoffmeyer; C Mischung; C Gille; C Ehlers; N Kücükceylan; M Abdel-Nour; A Gewies; H Peters; D Kaufmann; A Buske; S Tinschert; P Nürnberg
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

9.  Unusual features in a patient with neurofibromatosis type 1: multiple subcutaneous lipomas, a juvenile polyp in ascending colon, congenital intrahepatic portosystemic venous shunt, and horseshoe kidney.

Authors:  Cagatay Oktenli; Davut Gul; M Salih Deveci; Mutlu Saglam; Meena Upadhyaya; Peter Thompson; Claudia Consoli; Ismail H Kocar; Robert Pilarski; Xiao-Ping Zhou; Charis Eng
Journal:  Am J Med Genet A       Date:  2004-06-15       Impact factor: 2.802

10.  Soft-tissue perineurioma in a 20-year-old patient with neurofibromatosis type 1 (NF1): report of a case and review of the literature.

Authors:  Gregory G Ausmus; Melissa P Piliang; Wilma F Bergfeld; John R Goldblum
Journal:  J Cutan Pathol       Date:  2007-09       Impact factor: 1.587

View more
  5 in total

Review 1.  [Soft tissue tumors in hereditary tumor syndromes].

Authors:  A Agaimy
Journal:  Pathologe       Date:  2017-05       Impact factor: 1.011

2.  Recurrent multiple neurofibromatosis type  1 of the right lower limb.

Authors:  Leitao Huang; Xia Wu; Yi Ding; Lai Qi; Wei Li; Gendong Huang; Min Dai; Bin Zhang
Journal:  Orthopade       Date:  2018-03       Impact factor: 1.087

3.  Neurofibromatosis Type 1 With Cherubism-like Phenotype, Multiple Osteolytic Bone Lesions of Lower Extremities, and Alagille-syndrome: Case Report With Literature Survey.

Authors:  Reinhard E Friedrich; Jozef Zustin; Andreas M Luebke; Thorsten Rosenbaum; Martin Gosau; Christian Hagel; Felix K Kohlrusch; Ilse Wieland; Martin Zenker
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.155

4.  Repeated Multiple Neurofibromatosis Type 1 in the Right Lower Limb: A Case Report.

Authors:  Leitao Huang; Yi Ding; Lai Qi; Xia Wu; Wei Li; Gendong Huang; Min Dai; Bing Zhang
Journal:  World J Oncol       Date:  2017-05-04

5.  Jaffe-Campanacci syndrome or neurofibromatosis type 1: a case report of phenotypic overlap with detection of NF1 gene mutation in non-ossifying fibroma.

Authors:  Silvia Vannelli; Raffaele Buganza; Federica Runfola; Ilaria Mussinatto; Antonio Andreacchio; Luisa de Sanctis
Journal:  Ital J Pediatr       Date:  2020-05-11       Impact factor: 2.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.